News &amp; Updates

Pomegranate supplementation helps improve certain risk factors for cardiometabolic syndrome, including body weight, BMI, blood pressure, fasting blood glucose, total cholesterol, and high-density lipoprotein (HDL), according to a systematic review and meta-analysis.

Pomegranate supplementation mitigates several cardiometabolic risk factors

Original New Drug Application Approvals by US FDA (16-31 August 2025)

New drug applications approved by US FDA as of 16-31 August 2025 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16-31 August 2025)

Chronic insomnia promotes faster mental decline, dementia

People with chronic insomnia face an accelerated rate of cognitive decline and an increased risk of dementia, as shown in new research.

Chronic insomnia promotes faster mental decline, dementia

Exposure to CT scan may raise risks for pregnancy loss, congenital anomalies

Exposure to computed tomography (CT) imaging prior to pregnancy appears to increase the risks for spontaneous pregnancy loss and congenital anomalies, suggests a study. However, the mechanism driving this association remains unclear.

Exposure to CT scan may raise risks for pregnancy loss, congenital anomalies

Three-month DAPT post MI may suffice

Although guidelines recommend 12 months of dual antiplatelet therapy (DAPT) following a heart attack, results from the DUAL-ACS* trial appear to show otherwise.

Three-month DAPT post MI may suffice

23 Sep 2025

Gut microbiome awareness low, gut health practices high in SG

Knowledge and awareness of the gut microbiome are relatively low among the general population in Singapore, but practices of gut health modification are common, reports a study.

Gut microbiome awareness low, gut health practices high in SG

Favourable lifestyle helps prevent r-axSpA development

Individuals who adhere to a favourable lifestyle have a low risk of developing radiographic axial spondyloarthritis (r-axSpA), according to study.

Favourable lifestyle helps prevent r-axSpA development

Rifasutenizol tackles H. pylori infection

Rifasutenizol demonstrates efficacy in the treatment of Helicobacter pylori infection, according to the results of the phase III EVEREST-HP trial.

Rifasutenizol tackles H. pylori infection

Olezarsen lowers triglycerides in patients with moderate HTG, high CV risk

Treatment with olezarsen 50 or 80 mg significantly reduced triglyceride levels in patients with moderate hypertriglyceridaemia (HTG) and elevated cardiovascular (CV) risk compared with placebo, according to the Essence-TIMI 73b trial presented at ESC 2025.

Olezarsen lowers triglycerides in patients with moderate HTG, high CV risk

Should PPIs be avoided in mHSPC patients treated with upfront docetaxel?